Sutureless Surgical Orthotopic Implantation Technique of Primary and Metastatic Cancer in the Liver of Mouse Models.

Hepatocellular carcinoma PDOX cell line colon cancer liver metastasis nude mouse orthotopic patient tumor

Journal

In vivo (Athens, Greece)
ISSN: 1791-7549
Titre abrégé: In Vivo
Pays: Greece
ID NLM: 8806809

Informations de publication

Date de publication:
Historique:
received: 01 07 2020
revised: 24 07 2020
accepted: 27 07 2020
entrez: 4 11 2020
pubmed: 5 11 2020
medline: 22 6 2021
Statut: ppublish

Résumé

Surgical orthotopic implantation (SOI) is used to establish patient-derived orthotopic xenograft (PDOX) and other orthotopic mouse models. Orthotopic liver models can be challenging, as the liver parenchyma is prone to bleeding. The present report describes a sutureless method to implant tumors in the liver that reduces bleeding and procedural time. Human HCC cell-line (Huh-7-GFP) and CM2, a patient-derived colon-cancer liver metastasis, were used for sutureless SOI of tumor fragments in the liver of nude mice. A small cavity was formed on the liver surface. A solitary tumor fragment was implanted in the cavity without suturing to create hemostasis. Six weeks after sutureless SOI, the tumor volume of Huh-7-GFP (n=5) was 584.41±147.64 mm This novel method for establishing orthotopic liver-implantation mouse models is suitable for studies of liver cancer and liver metastases due to its simple procedure and potential high engraftment rate.

Sections du résumé

BACKGROUND/AIM OBJECTIVE
Surgical orthotopic implantation (SOI) is used to establish patient-derived orthotopic xenograft (PDOX) and other orthotopic mouse models. Orthotopic liver models can be challenging, as the liver parenchyma is prone to bleeding. The present report describes a sutureless method to implant tumors in the liver that reduces bleeding and procedural time.
MATERIALS AND METHODS METHODS
Human HCC cell-line (Huh-7-GFP) and CM2, a patient-derived colon-cancer liver metastasis, were used for sutureless SOI of tumor fragments in the liver of nude mice. A small cavity was formed on the liver surface. A solitary tumor fragment was implanted in the cavity without suturing to create hemostasis.
RESULTS RESULTS
Six weeks after sutureless SOI, the tumor volume of Huh-7-GFP (n=5) was 584.41±147.64 mm
CONCLUSION CONCLUSIONS
This novel method for establishing orthotopic liver-implantation mouse models is suitable for studies of liver cancer and liver metastases due to its simple procedure and potential high engraftment rate.

Identifiants

pubmed: 33144418
pii: 34/6/3153
doi: 10.21873/invivo.12149
pmc: PMC7811661
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3153-3157

Informations de copyright

Copyright© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Références

Anticancer Res. 2019 Oct;39(10):5339-5344
pubmed: 31570427
J Cell Biochem. 2009 Feb 1;106(2):279-84
pubmed: 19097136
Int J Cancer. 2015 Mar 1;136(5):E359-86
pubmed: 25220842
Tumour Biol. 2017 Mar;39(3):1010428317695923
pubmed: 28347231
Anticancer Res. 2019 Sep;39(9):4667-4671
pubmed: 31519565
Nat Rev Cancer. 2015 Aug;15(8):451-2
pubmed: 26422835
Oncotarget. 2017 Mar 21;8(12):19065-19073
pubmed: 27683127
Invest New Drugs. 1999;17(4):343-59
pubmed: 10759402
Anticancer Res. 2019 Jun;39(6):2739-2747
pubmed: 31177109
J Surg Oncol. 2015 Aug;112(2):119-24
pubmed: 26266663
Anticancer Res. 2020 May;40(5):2509-2514
pubmed: 32366395
Anticancer Res. 2015 Nov;35(11):5821-5
pubmed: 26504003
Int J Cancer. 1996 Apr 10;66(2):239-43
pubmed: 8603818
Ann Surg. 2006 Aug;244(2):254-9
pubmed: 16858188
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
PLoS One. 2016 Feb 05;11(2):e0148760
pubmed: 26849435
Clin Cancer Res. 2000 Jun;6(6):2556-61
pubmed: 10873112
Clin Cancer Res. 2000 Jun;6(6):2464-8
pubmed: 10873100
Lancet. 2014 Apr 26;383(9927):1490-1502
pubmed: 24225001
PLoS One. 2015 Oct 01;10(10):e0138752
pubmed: 26427050
Oncotarget. 2015 Sep 15;6(27):23306-22
pubmed: 26259234
Anticancer Res. 2012 Apr;32(4):1213-20
pubmed: 22493351
J Cell Biochem. 2010 Nov 1;111(4):1035-41
pubmed: 20672309
Proc Natl Acad Sci U S A. 1995 Dec 19;92(26):12085-9
pubmed: 8618849
J Surg Oncol. 2016 Dec;114(8):951-958
pubmed: 27696448

Auteurs

Hiroto Nishino (H)

Department of Surgery, University of California San Diego, San Diego, CA, U.S.A.
AntiCancer, Inc., San Diego, CA, U.S.A.
Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Hannah M Hollandsworth (HM)

Department of Surgery, University of California San Diego, San Diego, CA, U.S.A.
Department of Surgery, VA San Diego Healthcare System, San Diego, CA, U.S.A.

Norihiko Sugisawa (N)

Department of Surgery, University of California San Diego, San Diego, CA, U.S.A.
AntiCancer, Inc., San Diego, CA, U.S.A.

Jun Yamamoto (J)

Department of Surgery, University of California San Diego, San Diego, CA, U.S.A.
AntiCancer, Inc., San Diego, CA, U.S.A.

Yoshihiko Tashiro (Y)

Department of Surgery, University of California San Diego, San Diego, CA, U.S.A.
AntiCancer, Inc., San Diego, CA, U.S.A.

Sachiko Inubushi (S)

Department of Surgery, University of California San Diego, San Diego, CA, U.S.A.
AntiCancer, Inc., San Diego, CA, U.S.A.

Kazuyuki Hamada (K)

Department of Surgery, University of California San Diego, San Diego, CA, U.S.A.
AntiCancer, Inc., San Diego, CA, U.S.A.

Y U Sun (YU)

Department of Surgery, University of California San Diego, San Diego, CA, U.S.A.
AntiCancer, Inc., San Diego, CA, U.S.A.

Hyein Lim (H)

Department of Surgery, University of California San Diego, San Diego, CA, U.S.A.
AntiCancer, Inc., San Diego, CA, U.S.A.

Siamak Amirfakhri (S)

Department of Surgery, University of California San Diego, San Diego, CA, U.S.A.
Department of Surgery, VA San Diego Healthcare System, San Diego, CA, U.S.A.

Filemoni Filemoni (F)

Department of Surgery, University of California San Diego, San Diego, CA, U.S.A.
Department of Surgery, VA San Diego Healthcare System, San Diego, CA, U.S.A.

Robert M Hoffman (RM)

Department of Surgery, University of California San Diego, San Diego, CA, U.S.A.
AntiCancer, Inc., San Diego, CA, U.S.A.
Department of Surgery, VA San Diego Healthcare System, San Diego, CA, U.S.A.

Michael Bouvet (M)

Department of Surgery, University of California San Diego, San Diego, CA, U.S.A. mbouvet@ucsd.edu.
Department of Surgery, VA San Diego Healthcare System, San Diego, CA, U.S.A.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH